Retour
Fourchette du Jour
20,75 €
21,20 €
Fourchette 52 Semaines
19,50 €
34,13 €
Volume
332 263
Moyenne 50J / 200J
21,19 €
/
25,08 €
Clôture Précédente
21,13 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 33,9 | 0,3 |
| P/B | 1,8 | 2,9 |
| ROE % | 5,1 | 3,7 |
| Net Margin % | 6,0 | 3,8 |
| Rev Growth 5Y % | 4,3 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
25,00 €
+19.2%
P/E Prévisionnel
28,9
BPA Prévisionnel
0,73 €
Croissance BPA (est.)
+0,0%
CA Est.
330 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
0,00 €
0,00 € – 0,00 €
|
360 M | 1 |
| FY2027 |
0,82 €
0,81 € – 0,83 €
|
340 M | 3 |
| FY2026 |
0,73 €
0,72 € – 0,74 €
|
330 M | 3 |
Points Clés
Revenue grew 4,32% annually over 5 years — modest growth
Debt/Equity of 0,04 — conservative balance sheet
Generating 59,63M in free cash flow
P/E of 33,92 — premium valuation
Cash machine — converts 325,12% of earnings into free cash flow
Capital efficient — spends only 1,21% of revenue on capex
Croissance
Revenue Growth (5Y)
4,32%
Revenue (1Y)4,26%
Earnings (1Y)-8,32%
FCF Growth (3Y)-1,74%
Qualité
Return on Equity
5,14%
ROIC4,12%
Net Margin6,03%
Op. Margin6,66%
Sécurité
Debt / Equity
0,04
Current Ratio0,96
Interest Coverage0,00
Valorisation
P/E Ratio
33,92
P/B Ratio1,76
EV/EBITDA29,68
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,26% | Revenue Growth (3Y) | 4,38% |
| Earnings Growth (1Y) | -8,32% | Earnings Growth (3Y) | 9,80% |
| Revenue Growth (5Y) | 4,32% | Earnings Growth (5Y) | 33,10% |
| Profitability | |||
| Revenue (TTM) | 304,06M | Net Income (TTM) | 18,34M |
| ROE | 5,14% | ROA | 3,52% |
| Gross Margin | 64,74% | Operating Margin | 6,66% |
| Net Margin | 6,03% | Free Cash Flow (TTM) | 59,63M |
| ROIC | 4,12% | FCF Growth (3Y) | -1,74% |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 0,96 |
| Interest Coverage | 0,00 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 33,92 | P/B Ratio | 1,76 |
| P/S Ratio | 2,05 | PEG Ratio | -4,98 |
| EV/EBITDA | 29,68 | Dividend Yield | 0,01% |
| Market Cap | 622,14M | Enterprise Value | 600,66M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 304,06M | 291,65M | 279,06M | 266,83M | 256,71M |
| Net Income | 18,34M | 20,01M | 15,21M | 12,09M | 5,85M |
| EPS (Diluted) | 0,61 | 0,66 | 0,50 | 0,39 | 0,18 |
| Gross Profit | 196,86M | 193,71M | 184,04M | 175,68M | 165,68M |
| Operating Income | 20,24M | 21,29M | 16,02M | 12,45M | 8,06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 520,37M | 510,77M | 499,94M | 497,74M | 486,75M |
| Total Liabilities | 166,35M | 151,41M | 159,19M | 163,68M | 147,73M |
| Shareholders' Equity | 354,02M | 359,36M | 340,75M | 334,06M | 339,02M |
| Total Debt | 14,68M | 20,17M | 20,25M | 23,32M | 29,11M |
| Cash & Equivalents | 36,16M | 59,47M | 40,33M | 46,02M | 46,91M |
| Current Assets | 119,66M | 153,12M | 130,21M | 114,38M | 106,85M |
| Current Liabilities | 124,15M | 115,69M | 118,36M | 117,21M | 100,35M |